Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

National Research (NRC) Payables: 2010-2025

Historic Payables for National Research (NRC) over the last 16 years, with Q3 2025 value amounting to $7.8 million.

  • National Research's Payables fell 1448.61% to $7.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.8 million, marking a year-over-year decrease of 1448.61%. This contributed to the annual value of $8.8 million for FY2024, which is 2336.05% down from last year.
  • National Research's Payables amounted to $7.8 million in Q3 2025, which was down 1448.61% from $7.9 million recorded in Q2 2025.
  • Over the past 5 years, National Research's Payables peaked at $12.8 million during Q1 2024, and registered a low of $5.1 million during Q1 2021.
  • Moreover, its 5-year median value for Payables was $9.0 million (2023), whereas its average is $9.4 million.
  • Its Payables has fluctuated over the past 5 years, first tumbled by 5134.42% in 2021, then surged by 12400.78% in 2022.
  • National Research's Payables (Quarter) stood at $9.3 million in 2021, then dropped by 7.18% to $8.6 million in 2022, then skyrocketed by 32.8% to $11.4 million in 2023, then decreased by 23.36% to $8.8 million in 2024, then decreased by 10.84% to $7.8 million in 2025.
  • Its Payables stands at $7.8 million for Q3 2025, versus $7.9 million for Q2 2025 and $7.8 million for Q1 2025.